New amyloid beta-disaggregating agents: synthesis, pharmacological evaluation, crystal structure and molecular docking of N-(4-((7-chloroquinolin-4-yl)oxy)-3-ethoxybenzyl)amines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New amyloid beta-disaggregating agents: synthesis, pharmacological evaluation, crystal structure and molecular docking of N-(4-((7-chloroquinolin-4-yl)oxy)-3-ethoxybenzyl)amines

Published:2018 Issue:11 Volume:9 Page:1891-1904
ISSN:2040-2503
Container-title:MedChemComm
language:en
Short-container-title:Med. Chem. Commun.

Author:

Umar Tarana¹²³⁴^ORCID,Shalini Shruti⁵⁶⁷⁴,Raza Md Kausar⁸⁹¹⁰⁴,Gusain Siddharth⁵⁶⁷⁴,Kumar Jitendra¹¹¹¹²⁴,Ahmed Waqar¹²³⁴,Tiwari Manisha⁵⁶⁷⁴,Hoda Nasimul¹²³⁴

Affiliation:

1. Department of Chemistry

2. Jamia Millia Islamia (Central University)

3. New Delhi 110025

4. India

5. Dr. B. R. Ambedkar Centre for Biomedical Research

6. University of Delhi

7. New Delhi 110007

8. Department of Inorganic and Physical Chemistry

9. Indian Institute of Science

10. Bangalore 560012

11. Sardar Vallabhbhai Patel College

12. Bhabua

Abstract

N-(4-((7-Chloroquinolin-4-yl)oxy)-3-ethoxybenzyl)amines as new amyloid beta-disaggregating agents.

Funder

University Grants Commission

University of Delhi

Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy

Publisher

Royal Society of Chemistry (RSC)

Subject

Pharmaceutical Science,Biochemistry,Drug Discovery,Molecular Medicine,Pharmacology,Organic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2018/MD/C8MD00312B

Reference60 articles.

1. Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer’s Disease

2. Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer’s Disease

3. Minor Structural Variations of Small Molecules Tune Regulatory Activities toward Pathological Factors in Alzheimer's Disease

4. Multitarget Therapeutic Leads for Alzheimer’s Disease: Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Dual Inhibitors of Cholinesterases and β-Amyloid (Aβ) Aggregation

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiomic Profiling and Neuroprotective Bioactivity of Salvia Hairy Root-Derived Extracellular Vesicles in a Cellular Model of Parkinson’s Disease;International Journal of Nanomedicine;2024-09

2. Anticancer Therapies Based on Oxidative Damage: Lycium barbarum Inhibits the Proliferation of MCF-7 Cells by Activating Pyroptosis through Endoplasmic Reticulum Stress;Antioxidants;2024-06-11

3. Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer’s Disease;International Journal of Molecular Sciences;2024-01-01

4. Understanding Alzheimer’s Disease and its Metal Chelation Therapeutics: A Narrative Review;Current Pharmaceutical Design;2023-08

5. Multicomponent Petasis reaction for the identification of pyrazine based multi-target directed anti-Alzheimer's agents: In-silico design, synthesis, and characterization;European Journal of Medicinal Chemistry;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3